PRESS-RELEASE ·Filed Aug 5, 2026

PHGE

BiomX
BEARISH
Impact 5/10
Horizonweeks Processed1mo ago WireGlobeNewswire
Press release: m_and_a
Actionable Insight ▼ Bearish

This press release does not change the fundamental distress story — the company is burning cash, has a going concern qualification, and is conducting a massively dilutive ATM offering. The Motomea stake is a rounding error. Traders should focus on the ATM dilution trajectory and any NYSE delisting developments; the stock remains a short thesis until the capital structure stabilizes.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
PHGE ▼ -20.83% at T+20d
SHORT call ✓ call won +20.83% · α vs SPY +20.23% · entry $0.1800 → $0.1425
Next anchor: T+60d in 26d
Latest observation: T+33 -25.22% FF3 residual α
Entry anchored
Aug 5, 08:45 AM ET
via 1-min bar
T+1d
-11.22%
call +11.22% · α +11.06%
$0.1598
settled 8w ago
T+5d
-17.61%
call +17.61% · α +17.96%
$0.1483
settled 7w ago
T+20d
-20.83%
call +20.83% · α +20.23%
$0.1425
settled 4w ago
T+60d
—
call — · α —
—
in 26d

Price Chart

Loading chart...

Executive Summary

BiomX acquired a 10% stake in Motomea for $50,000 cash plus 1.3M restricted shares (pending NYSE approval), gaining access to electric motor testing and drone propulsion validation capabilities. The deal is tiny relative to the company's severe financial distress and massive ATM dilution risk, making it a negligible strategic move that does not address the existential cash crunch.

Key Financial Metrics

Deal Value
$303.5K

Key Facts

  • BiomX acquired a 10% stake in Motomea for $50,000 cash and 1.3M restricted shares (subject to NYSE approval)
  • The deal includes an option to acquire control of Motomea at 2x net revenue (FY2027) or 4x EBITDA (FY2028), times 90%
  • BiomX has a market cap of ~$5M and is in severe financial distress, with a $9.145M ATM offering that could dilute shares by over 450%
  • The company has a going concern qualification and faces potential NYSE American delisting
  • Historical performance on PHGE shows bearish calls have been correct (avg +48.8% alpha at T+20 for short calls), while neutral calls have been heavily wrong (avg -59.1% alpha)

Financial Impact

Deal value of $50,000 cash plus 1.3M restricted shares (value ~$253,500 at $0.195/share) — total ~$303,500, immaterial relative to the company's market cap and cash needs

dilutioncash burn

Risk Factors

  • NYSE American may not approve the restricted share issuance, killing the deal
  • The option to acquire control of Motomea is unlikely to be exercised given BiomX's cash constraints
  • The ATM offering could continue to dilute shareholders severely, potentially pushing the stock below $0.10
  • Delisting risk remains high, which would further impair liquidity and access to capital

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3339318
20 reports for PHGE
Performance horizon
60% Hit rate 6 of 10 directional calls best @ T+20▲ +62.36%Jun 16, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 5, 2026